Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis

To explore the efficacy and safety of fecal microbiota transplantation (FMT) as a treatment approach for ulcerative colitis (UC), a comprehensive systematic review and meta-analysis of randomized controlled trials was conducted. To collect and evaluate randomized controlled trials of high quality on...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jing, Chen, Yexin, Liu, Yan, Lin, Lin, Lin, Xiujuan, Gong, Wenxiu, Xia, Rongmu, He, Jianquan, Sheng, Jianwen, Cai, Huimei, Xiao, Chuanxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475461/
https://www.ncbi.nlm.nih.gov/pubmed/37661203
http://dx.doi.org/10.1038/s41598-023-41182-6
_version_ 1785100723710590976
author Feng, Jing
Chen, Yexin
Liu, Yan
Lin, Lin
Lin, Xiujuan
Gong, Wenxiu
Xia, Rongmu
He, Jianquan
Sheng, Jianwen
Cai, Huimei
Xiao, Chuanxing
author_facet Feng, Jing
Chen, Yexin
Liu, Yan
Lin, Lin
Lin, Xiujuan
Gong, Wenxiu
Xia, Rongmu
He, Jianquan
Sheng, Jianwen
Cai, Huimei
Xiao, Chuanxing
author_sort Feng, Jing
collection PubMed
description To explore the efficacy and safety of fecal microbiota transplantation (FMT) as a treatment approach for ulcerative colitis (UC), a comprehensive systematic review and meta-analysis of randomized controlled trials was conducted. To collect and evaluate randomized controlled trials of high quality on FMT for UC, we searched a number of databases, including PubMed, Web of Science, Cochrane, Embase, and Medline, for studies published between the establishment of the databases and March 2023. We conducted a meta-analysis of the studies using Review Manager software (version 5.4.1) to determine the differences in rates of remission and adverse reactions between the FMT group and the control group, utilizing the risk ratio (RR) and 95% confidence interval (CI) to combine our findings. A total of 13 randomized controlled trials (RCTs) on the efficacy of FMT in patients with UC were included in the study, in which 580 patients participated, including 293 patients treated with FMT and 287 control subjects. Meta-analysis revealed that clinical remission was significantly better in the FMT group than in the control group [RR = 1.73; 95% CI = (1.41, 2.12); P < 0.00001]; endoscopic remission was significantly better in the FMT group than in the control group [RR = 1.74; 95% CI = (1.24, 2.44); P = 0.001]. Additionally, there were no significant differences in the incidence of adverse reactions between the two groups [RR = 1.00; 95% CI = (0.86, 1.15); P = 0.96]. Fecal microbiota transplantation has shown potential as a therapeutic intervention for inducing clinical remission in ulcerative colitis UC; nevertheless, the attainment of endoscopic remission and the maintenance of long-term remission continue to present challenges. Safety concerns persist throughout the treatment process, necessitating the implementation of measures to augment both safety and success rates.
format Online
Article
Text
id pubmed-10475461
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104754612023-09-05 Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis Feng, Jing Chen, Yexin Liu, Yan Lin, Lin Lin, Xiujuan Gong, Wenxiu Xia, Rongmu He, Jianquan Sheng, Jianwen Cai, Huimei Xiao, Chuanxing Sci Rep Article To explore the efficacy and safety of fecal microbiota transplantation (FMT) as a treatment approach for ulcerative colitis (UC), a comprehensive systematic review and meta-analysis of randomized controlled trials was conducted. To collect and evaluate randomized controlled trials of high quality on FMT for UC, we searched a number of databases, including PubMed, Web of Science, Cochrane, Embase, and Medline, for studies published between the establishment of the databases and March 2023. We conducted a meta-analysis of the studies using Review Manager software (version 5.4.1) to determine the differences in rates of remission and adverse reactions between the FMT group and the control group, utilizing the risk ratio (RR) and 95% confidence interval (CI) to combine our findings. A total of 13 randomized controlled trials (RCTs) on the efficacy of FMT in patients with UC were included in the study, in which 580 patients participated, including 293 patients treated with FMT and 287 control subjects. Meta-analysis revealed that clinical remission was significantly better in the FMT group than in the control group [RR = 1.73; 95% CI = (1.41, 2.12); P < 0.00001]; endoscopic remission was significantly better in the FMT group than in the control group [RR = 1.74; 95% CI = (1.24, 2.44); P = 0.001]. Additionally, there were no significant differences in the incidence of adverse reactions between the two groups [RR = 1.00; 95% CI = (0.86, 1.15); P = 0.96]. Fecal microbiota transplantation has shown potential as a therapeutic intervention for inducing clinical remission in ulcerative colitis UC; nevertheless, the attainment of endoscopic remission and the maintenance of long-term remission continue to present challenges. Safety concerns persist throughout the treatment process, necessitating the implementation of measures to augment both safety and success rates. Nature Publishing Group UK 2023-09-03 /pmc/articles/PMC10475461/ /pubmed/37661203 http://dx.doi.org/10.1038/s41598-023-41182-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Feng, Jing
Chen, Yexin
Liu, Yan
Lin, Lin
Lin, Xiujuan
Gong, Wenxiu
Xia, Rongmu
He, Jianquan
Sheng, Jianwen
Cai, Huimei
Xiao, Chuanxing
Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
title Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
title_full Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
title_fullStr Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
title_full_unstemmed Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
title_short Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
title_sort efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475461/
https://www.ncbi.nlm.nih.gov/pubmed/37661203
http://dx.doi.org/10.1038/s41598-023-41182-6
work_keys_str_mv AT fengjing efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT chenyexin efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT liuyan efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT linlin efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT linxiujuan efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT gongwenxiu efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT xiarongmu efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT hejianquan efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT shengjianwen efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT caihuimei efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis
AT xiaochuanxing efficacyandsafetyoffecalmicrobiotatransplantationinthetreatmentofulcerativecolitisasystematicreviewandmetaanalysis